Localization of LRRK2 to membranous and vesicular structures in mammalian brain

被引:423
作者
Biskup, Saskia
Moore, Darren J.
Celsi, Fulvio
Higashi, Shinji
West, Andrew B.
Andrabi, Shaida A.
Kurkinen, Kaisa
Yu, Seong-Woon
Savitt, Joseph M.
Waldvogel, Henry J.
Faull, Richard L. M.
Emson, Piers C.
Torp, Reldun
Ottersen, Ole P.
Dawson, Ted M.
Dawson, Valina L.
机构
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Univ Oslo, Inst Basic Med Sci, Ctr Mol Biol & Neurosci, N-0316 Oslo, Norway
[4] Juntendo Univ, Sch Med, Dept Psychiat, Bungko Ku, Tokyo, Japan
[5] Babraham Inst, Neurobiol Programme, Cambridge, MA USA
[6] Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand
[7] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA
[8] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD USA
关键词
D O I
10.1002/ana.21019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The PARK8 gene responsible for late-onset autosomal dominant Parkinson's disease encodes a large novel protein of unknown biological function termed leucine-rich repeat kinase 2 (LRRK2). The studies herein explore the localization of LRRK2 in the mammalian brain. Methods: Polyclonal antibodies generated against the amino or carboxy termini of LRRK2 were used to examine the biochemical, subcellular, and immunohistochemical distribution of LRRK2. Results: LRRK2 is detected in rat brain as an approximate 280kDa protein by Western blot analysis. Subcellular fractionation demonstrates the presence of LRRK2 in microsomal, synaptic vesicle-enriched and synaptosomal cytosolic fractions from rat brain, as well as the mitochondrial outer membrane. Immunohistochemical analysis of rat and human brain tissue and primary rat cortical neurons, with LRRK2-specific antibodies, shows widespread neuronal-specific labeling localized exclusively to punctate structures within perikarya, dendrites, and axons. Confocal colocalization analysis of primary cortical neurons shows partial yet significant overlap of LRRK2 immunoreactivity with markers specific for mitochondria and lysosomes. Furthermore, ultrastructural analysis in rodent basal ganglia detects LRRK2 immunoreactivity associated with membranous and vesicular intracellular structures, including lysosomes, endosomes, transport vesicles, and mitochondria. Interpretation: The association of LRRK2 with a variety of membrane and vesicular structures, membrane-bound organelles, and microtubules suggests an affinity of LRRK2 for lipids or lipid-associated proteins and may suggest a potential role in the biogenesis and/or regulation of vesicular and membranous intracellular structures within the mammalian brain.
引用
收藏
页码:557 / 569
页数:13
相关论文
共 24 条
  • [1] Roc, a Ras/GTPase domain in complex proteins
    Bosgraaf, L
    Van Haastert, PJM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1643 (1-3): : 5 - 10
  • [2] Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1:: implications for Lewy-body formation in Parkinson disease
    Chung, KKK
    Zhang, Y
    Lim, KL
    Tanaka, Y
    Huang, H
    Gao, J
    Ross, CA
    Dawson, VL
    Dawson, TM
    [J]. NATURE MEDICINE, 2001, 7 (10) : 1144 - 1150
  • [3] DAWSON VL, 1993, J NEUROSCI, V13, P2651
  • [4] A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
    Funayama, M
    Hasegawa, K
    Kowa, H
    Saito, M
    Tsuji, S
    Obata, F
    [J]. ANNALS OF NEUROLOGY, 2002, 51 (03) : 296 - 301
  • [5] LRRK2 expression linked to dopamine-innervated areas
    Galter, D
    Westerlund, M
    Carmine, A
    Lindqvist, E
    Sydow, O
    Olson, L
    [J]. ANNALS OF NEUROLOGY, 2006, 59 (04) : 714 - 719
  • [6] The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
    Gloeckner, CJ
    Kinkl, N
    Schumacher, A
    Braun, RJ
    O'Neill, E
    Meitinger, T
    Kolch, W
    Prokisch, H
    Ueffing, M
    [J]. HUMAN MOLECULAR GENETICS, 2006, 15 (02) : 223 - 232
  • [7] Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism
    Hauser, MA
    Li, YJ
    Xu, H
    Noureddine, MA
    Shao, YS
    Gullans, SR
    Scherzer, CR
    Jensen, RV
    McLaurin, AC
    Gibson, JR
    Scott, BL
    Jewett, RM
    Stenger, JE
    Schmechel, DE
    Hulette, CM
    Vance, JM
    [J]. ARCHIVES OF NEUROLOGY, 2005, 62 (06) : 917 - 921
  • [8] LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain
    Korr, D
    Toschi, L
    Donner, P
    Pohlenz, HD
    Kreft, B
    Weiss, B
    [J]. CELLULAR SIGNALLING, 2006, 18 (06) : 910 - 920
  • [9] Leucine-rich repeat kinase 2: A new player with a familiar theme for Parkinson's disease pathogenesis
    Li, CJ
    Beal, MF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (46) : 16535 - 16536
  • [10] Moore D, 2000, J COMP NEUROL, V421, P374, DOI 10.1002/(SICI)1096-9861(20000605)421:3<374::AID-CNE6>3.0.CO